Clinical trial
Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast…
NCT00096369 · University of Texas Southwestern Medical Center, Other · Terminated
Key facts
| NCT number | NCT00096369 |
|---|---|
| Title | Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer |
| Official title | An Exploratory Study to Identify Potential Surrogate Endpoint Biomarkers That Are Modulated by Tamoxifen vs. Placebo in Women With an Increased Risk for Breast Cancer |
| Lead sponsor | University of Texas Southwestern Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | tamoxifen citrate |
| Enrollment | 130 |
| Start date | Feb 1, 2000 |
| Primary completion | Mar 15, 2007 |
| Completion | Mar 15, 2007 |
| First posted | Nov 9, 2004 |
| Last update posted | Jan 24, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: